We’re Danaher - a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health.

Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics.

Feb 17, 2026 · Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global medical innovator, today announced that it has entered into a definitive agreement pursuant to which Danaher …

Feb 17, 2026 · The companies said on Tuesday that Danaher will pay $180 per share to buy Masimo. The offer represents a premium of 38.3% to Masimo's last close.

Feb 17, 2026 · /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to...

Feb 17, 2026 · Irvine-based Masimo is being acquired by Danaher Corp. in a deal with an enterprise value of about $9.9 billion, allowing it to gain a foothold in the medical supply business.

Feb 18, 2026 · Danaher (NYSE: DHR) is acquiring Masimo (NASDAQ: MASI) for $9.9 billion in an all-cash deal that values the medical technology company at $180 per share. The transaction, …

Feb 17, 2026 · Summary and Market Outlook The Danaher-Masimo deal is a landmark $9.9 billion transaction that marks the end of an era for Masimo as an independent entity and the beginning of a …

4 days ago · Irvine medical device maker Masimo has entered an agreement to be acquired by Danaher, owner of Brea-based Beckman Coulter, in a $9.9 billion deal.

Feb 17, 2026 · Danaher to buy Masimo for $9.9B to boost diagnostics portfolio Masimo’s board considered other potential partners before determining Danaher was an “ideal fit,” executives at the …